Autoantibodies to coagulation factors

Haemophilia

Volumn 16, Issue 102, 2010, Pages 56-60

  Saint Remy, J M R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Autoimmunity; Coagulation factors; Tolerance

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; COMPLEMENT COMPONENT C2; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; BLOOD CLOTTING; COMPLEX FORMATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

AUTOANTIBODIES; AUTOIMMUNITY; FACTOR VIII; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES;

EID: 77953186012     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02229.x     Document Type: Article

References (20)

1. Pitkanen J, Peterson P. Autoimmune regulator: from loss of function to autoimmunity. Genes Immun 2003, 4:12-21.
2. Goodnow CC. Pathways for self tolerance and the treatment of autoimmune diseases. Lancet 2001, 357:2115-21.
3. Zhang L, Nakayama M, Eisenbarth GS. Insulin as an autoantigens in NOD/human diabetes. Curr Opin Immunol 2008, 20:111-8.
4. Sallah A, Saint-Remy JMR. Autoantibodies to coagulation factors. Clinical Hematology 2006, 842-54. Young NS, Gerson SLHigh KA. In, eds, chapter 65, Philadelphia, PA, Elsevier
5. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
6. Walker LSK, Abbas AK. The enemy within; keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002, 2:11-9.
7. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007, 7:585-98.
8. Kurosaki T. Regulation of B cell fates by BCR signaling components. Curr Opin Immunol 2002, 14:341-7.
9. Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally-occurring anergic B cells? Nat Rev Immunol 2007, 7:633-43.
10. Perez-Diez A, Joncker NT, Choi K. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 2007, 109:5346-54.
11. Gilles JGG, Saint-Remy JMR. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. J Clin Invest 1994, 94:1496-505.
12. Sercarz EE. Driver clones and determinant spreading. J Autoimmun 2000, 14:275-7.
13. Suri A, Levisetti MG, Unanue ER. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr Opin Immunol 2008, 20:105-10.
14. Gilles JG, Arnout J, Vermylen J, Saint-Remy JM. Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. Blood 1993, 82:2452-61.
15. Astermark J, Oldenburg J, Carlson J. Polymorphisms in the TNFA gene and risk of inhibitor development in patients with hemophilia A. Blood 2006, 108:3739-45.
16. Jacquemin MG, Vantomme V, Buhot C. CD4+ T cell clones specific for wild-type factor VIII: a molecular mechanism responsible for the higher incidence of inhibitor in mild/moderate hemophilia A patients with mutations in the C1 domain. Blood 2003, 101:1351-8.
17. van Den Brink EN, Turenhout EA, Davies J. Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes. Blood 2000, 95:558-63.
18. Kessler CM, Asatiani E. Acquired inhibitors to factor VIII. Textbook of Hemophilia 2005, 86-90. Lee C, Berntorp EHoots WK. In, eds, Chapter 15, Oxford, UK, Blackwell Publisher
19. Spiegel PC, Jacquemin M, Saint-Remy JMR, Stoddard BL, Pratt KP. Structure of a factor VIII C2 domain:IgG4κ Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII. Blood 2001, 98:13-9.
20. Barrow RT, Healey JF, Jacquemin MG, Saint-Remy JMR, Lollar P. Antigenicity of putative phospholipid membrane binding residues in factor VIII. Blood 2001, 97:169-74.